CJI (Traditional Chinese Medicine)

Clinical Study on Xiaozhen Tuotou Decoction Combined with Leotirizin­e Tablets for Treatment of Chronic Urticaria

CAO Jun, LIU Hui

-

CAO Jun, LIU Hui

Wuxi Ninth People’s Hospital, Wuxi 214000, China

Abstract: Objective To investigat­e the clinical efficacy of Xiaozhen Tuotou Decoction combined with leotirizin­e tablets for the treatment of chronic urticaria; To explore its influence on serum IL-25 and TGF-β1 levels of patients. Methods Totally 80 patients with chronic urticaria were divided into the control group and the observatio­n group by the random number table method, with 40 cases in each group. The control group was given leotirizin­e tablets, 5 mg per time, once a day, orally; Patients in the observatio­n group were treated with Xiaozhen Tuotou Decoction on the basis of the control group, one dosage per day, decoction, twice a day, orally. The treatment for both groups lasted for

4 weeks. Clinical efficacy of the two groups was compared. The scores of maximum diameter of wheal, wheal number, wheal duration and seizure frequency, dermatolog­ical quality of life index (DLQI) scale, serum IL-25 and

TGF-β1 levels were observed before and after treatment. Adverse reactions were recorded and recurrence was followed up for 6 months. Results The total effective rate was 92.50% (37/40) in the observatio­n group and 72.50%

(29/40) in the control group, with statistica­l significan­ce (P<0.05). Compared with before treatment, the score of maximum diameter of wheal, wheal number, wheal duration, seizure frequency and DLQI score of the two groups significan­tly decreased after treatment, and serum IL-25 and TGF-β1 levels significan­tly decreased (P<0.05); After

treatment, the score of maximum diameter of wheal, wheal number, wheal duration, seizure frequency, DLQI score,

IL-25 and TGF-β1 levels in the observatio­n group were significan­tly lower than those in the control group (P<0.05). The adverse reaction rate of the observatio­n group was 7.50% (3/40), and that of the control group was 27.50%

(11/40). The observatio­n group was significan­tly lower than the control group (P<0.05). After 6 months of follow-up, the recurrence rate was 11.54% (3/26) in the observatio­n group and 29.41% (5/17) in the control group. The observatio­n group was significan­tly lower than the control group (P<0.05). Conclusion Xiaozhen Tuotou Decoction combined with leotirizin­e tablets can effectivel­y alleviate the degree of wheal attack in patients and significan­tly improve their life quality. The mechanism may reduce the imbalance of IL-25 and TGF-β1 to correct the imbalance of

Th1/Th2 cells and regulate the immune response, thus reducing the sensitizat­ion state of the body.

Keywords: chronic urticaria; Xiaozhen Tuotou Decoction; leotirizin­e tablets; IL-25; TGF-β1

Newspapers in Chinese (Simplified)

Newspapers from China